Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients

Journal of Clinical Immunology

Volumn 18, Issue 3, 1998, Pages 235-240

  Dawood, M R ^a,c   Conway, B ^b   Patenaude, P ^b   Janmohamed, F ^b   Montaner, J S G ^b   O'Shaughnessy, M V ^b   Hammond, G W ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Brit Colombia Ctr Excellence H   (Canada)

^c CADHAM PROVINCIAL LABORATORY   (Canada)

Author keywords

Abnormalities; B cells; HIV; Plasma viremia; Viral load

Indexed keywords

CD22 ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; PHENOTYPE; PRIORITY JOURNAL; SEROCONVERSION; VIREMIA; VIRUS LOAD;

EID: 0031808507     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020539207593     Document Type: Article

References (24)

1. Martinez-Maza O, Crabb E, Mitsuyasu RT, Fahey JL, Giorgi JV: Infection wilh the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol 138:3720-3724, 1987
2. Yarchoan R, Redfield RR, Broder S: Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders: contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy associated virus. J Clin Invest 78:439-147, 1986
3. Pahwa SG, Quilop MTJ, Lange M, Pahwa RN, Grieco MH: Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome. Ann Intern Med 101: 757-763, 1984
4. Amadori A, Zamurchi R, Ciminale V, Mistro AD, Siervo S, Alberti A, Colombatti M, Chieco-Bianchi L: HIV-1-specitic B cell activation: a major constituent of spontaneous B cell activation during HIV-I infection. J Immunol 143:2146-2152, 1989
5. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS: Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309:453-458, 1983
6. Reddy MM, Goetz RR, Gorman JM, Grieco MH, Chess L, Lederman S: Human Immunodeficiency Virus type-1 infection of homosexual men is accompanied by a decrease in circulating B cells. J Acq Imm Del Syndr 4:428-434, 1991
7. Lane HC, Fauci AS: Immunological abnormalities in the acquired immunodeficiency syndrome. Annu Rev Immunol 3:477-500, 1985
8. Benedetto A, Di Caro A, Camporiondo MP, Gallone D, Zaniratti S, Tozzi V, Elia G: Identification of a CD21 receptor-deficient, non-Ig-secreting peripheral B lymphocyte subset in HIV-seropositive drug abusers. Clin Immunol Immunopathol 62:139-147, 1992
9. Munson LG, Scott ME, Landay AL, Spear GT: Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection. Clin Immunol Immunopathol 75:20-25, 1995
10. Scott ME, Landay AL, Lint TF, Spear GT: In vivo decrease in the expression of complement receptor 2 on B-cells in HIV infection. AIDS 7:37-41, 1993
11. Indraccolo S, Mion M, Zamarchi R, Veronesi A, Veronese ML, Panozzo M, Betterle C, Barelli A, Borri A, Amadori A, Chieco-Bianchi L: B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5 + and CD5- B cell subsets. J Clin Immunol 13:381-388, 1993
12. Zolla-Pazner S, Des Jarlais DC, Friedman SR, Spira TJ, Marmor M, Holzman R, Mildvan D, Yancovitz S, Mathur-Wagh U, Garber J, El-Sadr W, Cohen H, Smith D, Kalyanaraman VS, Kaplan JE, Fishhein DB: Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: Implications for immunologic classification of the disease. Proc Natl Acad Sci USA 84:5404-5408, 1987
13. Amadori A, and Chieco-Bianchi L: B cell activation and HIV 1 infection: deeds and misdeeds. Immunol Today 11:374-379, 1990
14. Pinching AJ: Antibody responses in HIV infection. Clin Exp Immunol 84: 181-184, 1991
15. Boyd JE, James K: B cell responses to HIV and the development of human monoclonal antibodies. Clin Exp Immunol 88: 189-202, 1992
16. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M: B-cell immunodcticiency in acquired immune deficiency syndrome. JAMA 251:1447-1449, 1984
17. Simberkoff MS, El Sadr W, Schiffman G, Rahal JJ Jr.: Streptococcus pneumonia intections and bacteraemia in patients with acquired immune deficiency syndrome, with report of pneumococcal vaccine failure. Am Rev Respir Dis 130:1174-1176, 1984
18. Bernstein LJ, Ochs HD, Wedgwood RJ, Rubinstein A: Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr 107:352-357, 1985
19. Ballet JJ, Sulcebe G, Coudere LJ, Danon F, Rabian C, Lathrop M, Clauvel JP, Seligmann M: Impaired anti-pneumococcal antibody response in patients vvilh AIDS-related persistent generalized lymphadenopathy. Clin Exp Immunol 68:479-487, 1987
20. Janoff EN, Douglas JM Jr, Gabriel M, Blaser MJ, Davidson AJ, Cohn DL, Judson FN: Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type I. J Infect Dis 158:983-990, 1988
21. Opravil M, Fierz W, Malter L, Blaser J, Luthy R: Poor antibody response after tetanus and pneumococcal vaccination in immuno-compromised. HIV-infected patients. Clin Exp Immunol 84:185-189, 1991
22. Brena AH, Cooper ER, Cabral HJ, Pelton SI: Antibody response to measles and rubella vaccine by children with HIV infection. J Acq Imm Del Syndrome 6:1125-1129, 1993
23. Rasmussen AM, Smeland EB, Erikslein BK, Caignault L, Funderud S: A new method for detachment of Dynabeads from positively selected B lymphocytes. J Immunol Methods 146:195-202, 1992
24. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170, 1996